POSC52 Cost-Effectiveness of Atezolizumab in Association with Bevacizumab for Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Using a French Real-World Evidence Database
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.457
https://www.valueinhealthjournal.com/article/S1098-3015(21)02252-X/fulltext
Title :
POSC52 Cost-Effectiveness of Atezolizumab in Association with Bevacizumab for Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Using a French Real-World Evidence Database
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02252-X&doi=10.1016/j.jval.2021.11.457
First page :
Section Title :
Open access? :
No
Section Order :
11229